Diabetes and periodontitis are two of the most prevalent diseases worldwide that negatively impact the quality of life of the individual suffering from them. They are part of the chronic inflammatory disease group or, as recently mentioned, non-communicable diseases, with inflammation being the meeting point among them. Inflammation hitherto...
-
October 10, 2022 (v1)PublicationUploaded on: March 24, 2023
-
April 7, 2016 (v1)Publication
A review of pathological mechanisms that can explain the relationship between periodontitis and cardiovascular disease (CVD) is necessary to improve the management of both conditions. Metabolic syndrome is a combination of obesity, hypertension, impaired glucose tolerance or diabetes, hyperinsulinemia, and dyslipidemia. All these have been...
Uploaded on: March 27, 2023 -
March 17, 2017 (v1)PublicationCould NLRP3–inflammasome be a cardiovascular risk biomarker in acute myocardial infarction patients?
Conventional cardiovascular risk factors (CVRFs) are accepted to identify asymptomatic individuals with high risk of acute myocardial infarction (AMI). However, AMI affects many patients previously classified at low risk. New biomarkers are needed to improve risk prediction. We propose to evaluate the NLRP3–inflammasome complex as a potential...
Uploaded on: March 27, 2023 -
February 27, 2015 (v1)Publication
No description
Uploaded on: December 4, 2022 -
November 7, 2022 (v1)Publication
Aims: Tay–Sachs and Sandhoff diseases (GM2 gangliosidosis) are autosomal recessive disorders of lysosomal function that cause progressive neurodegeneration in infants and young children. Impaired hydrolysis catalysed by β-hexosaminidase A (HexA) leads to the accumulation of GM2 ganglioside in neuronal lysosomes. Despite the storage phenotype,...
Uploaded on: December 2, 2022